Research and Development

Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …

Clinical research organisation TKL Research has appointed Roxanne Tavakkol to the position of vice president, regulatory and scientific services. Tavakkol …

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …

England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …

Healthcare consultancy firm InVentiv Health has created two new positions
 to lead its growing business opportunities in Europe and Asia. …

The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …

Sophie McGrath has joined law firm Brown Rudnick as a partner and is to focus on life sciences at the …

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

Speciality biopharma firm Circassia has appointed Dr Francesco Granata as its non-executive chairman.  Granata is executive in Residence at Warburg …

Zaicom International which focusses on comms, market research and regulatory solutions in healthcare has appointed Stuart Cossins as its chief …